CCL18/DC‐CK‐1/PARC up‐regulation in hypersensitivity pneumonitis

Hypersensitivity pneumonitis (HP) is a lung inflammatory disorder characterized by accumulation of T lymphocytes. However, the mechanisms implicated in this process remain undefined. We examined the expression of dendritic cell (DC)‐derived CC chemokine 1 (CK1)/CCL18, a chemokine putatively involved in naive T cell recruitment, in lungs from 10 patients with HP, 9 patients with idiopathic pulmonary fibrosis (IPF), and 20 healthy lungs. CCL18 was measured by real‐time quantitative PCR and localized in lungs by in situ hybridization and immunohistochemistry. CCL18 expression was significantly increased in lungs affected by HP in comparison with lungs affected by IPF (2,085±393 vs. 1,023±110; P<0.05) and controls (2,085±393 vs. 467±94; P<0.01). Macrophages, DCs, and alveolar epithelial cells were the main sources of CCL18. There was a direct correlation between the levels of tissue CCL18 and the number of lymphocytes in the bronchoalveolar lavage fluids. High levels of CCL18 were detected in the subacute rather than the chronic phase of HP. These findings suggest a role for CCL18 in the pathogenesis of HP.

[1]  Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. , 1990, The American review of respiratory disease.

[2]  R. Zambello,et al.  Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. , 1990, Journal of immunology.

[3]  W. Thurlbeck,et al.  Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. , 1991, The American review of respiratory disease.

[4]  R. Chapela,et al.  Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. , 1993, The American review of respiratory disease.

[5]  D. Lamb,et al.  A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) , 1995, Clinical and experimental immunology.

[6]  M. Denis.  Proinflammatory cytokines in hypersensitivity pneumonitis. , 1995, American journal of respiratory and critical care medicine.

[7]  Y. Sakaki,et al.  A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.

[8]  T. Mcclanahan,et al.  A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.

[9]  S. Goerdt,et al.  Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.

[10]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[11]  T. Isobe,et al.  [Hypersensitivity pneumonitis]. , 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[12]  S. Menon,et al.  Lungkine, a novel CXC chemokine, specifically expressed by lung bronchoepithelial cells. , 1999, Journal of immunology.

[13]  A. Hughes,et al.  Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes. , 1999, Genomics.

[14]  A. Hughes,et al.  Chemokine PARC Gene (SCYA18) Generated by Fusion of Two MIP-1α/LD78α-like Genes , 1999 .

[15]  M. Wills-Karp.  Immunologic basis of antigen-induced airway hyperresponsiveness. , 1999, Annual review of immunology.

[16]  M. Selman,et al.  Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. , 1999, American journal of respiratory and critical care medicine.

[17]  E. Hoffman,et al.  Interstitial lung disease: A quantitative study using the adaptive multiple feature method. , 1999, American journal of respiratory and critical care medicine.

[18]  M. Ando,et al.  Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. , 1999, Journal of immunology.

[19]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[20]  M. Selman,et al.  TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? , 2000, American journal of physiology. Lung cellular and molecular physiology.

[21]  M. Gaxiola,et al.  Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. , 2000, American journal of respiratory and critical care medicine.

[22]  C. Caux,et al.  Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1 , 2000, The Journal of Immunology.

[23]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[24]  C. Yutani,et al.  Accumulation of Lymphocytes, Dendritic Cells, and Granulocytes in the Aortic Wall Affected by Takayasu's Disease , 2000, Angiology.

[25]  F. Marumo,et al.  Expression of C-C Chemokines is Associated with Portal and Periportal Inflammation in the Liver of Patients with Chronic Hepatitis C , 2000, Laboratory Investigation.